NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Wednesday 21 November 2012

Matthey fine chems perform well in H1

Johnson Matthey reported sales fell 2% to £138m in H1 for its fine chemicals while operating profit rose 14% to £37.2m. Of this, sales in Matthey's API manufacturing business fell 3% to £99m.
Johnson Matthey

No comments: